EKF Diagnostics Holdings PLC Notice of Change of AGM Venue and Dividend Update (6383X)
May 05 2021 - 5:14AM
UK Regulatory
TIDMEKF
RNS Number : 6383X
EKF Diagnostics Holdings PLC
05 May 2021
EKF Diagnostics Holdings plc
("EKF", the "Company" or the "Group")
Notice of Change of AGM Venue and Updated Dividend Timetable
Further to the announcement on 23 April 2021, EKF Diagnostics
Holdings plc (AIM: EKF), the AIM-listed point-of-care business,
announces a change in venue of its Annual General Meeting ('AGM'),
which will now take place at Harwood Capital, 6 Stratton Street,
Mayfair, W1J 8LD on 19 May 2021 at 10.30am.
As previously announced, the Company is providing a facility for
shareholders to join the AGM either online or telephonically and
there will be an opportunity for shareholders to ask questions. In
order to facilitate the process, the Directors would request that
shareholders register for the meeting and submit questions in
advance, before 10.30 a.m. 17 May 2021.
To register for dial-in details and to submit any questions
please contact Walbrook PR via email at ekf@walbrookpr.com or call
+44 (0)20 7933 8787
No other details have changed.
Shareholders are reminded that due to the UK Government
restrictions on public gatherings as a consequence of the COVID-19
pandemic, it will not be possible for shareholders to attend the
AGM in person. The Board, with this in mind and in accordance with
the Corporate Insolvency and Governance Act 2020, has therefore
decided that the AGM will be held as a 'closed' meeting with the
minimum number of Directors and officers who hold shares, present,
to form the necessary quorum. Regrettably, other shareholders will
not be permitted to attend the meeting in person.
Copies of the Annual Report and Accounts and Notice of AGM are
available on the Company's website here:
https://www.ekfdiagnostics.com/documents-reports.html
Updated Dividend Timetable
Further to the announcement of its final year results released
on 30 March 2021, and subject to shareholder approval at the
upcoming AGM, the dividend payment to shareholders of 1.1 pence per
ordinary share will be made in accordance with the following
timetable:
Ex-dividend date 4 November 2021
Record date 5 November 2021
----------------
Payment date 1 December 2021
----------------
EKF Diagnostics Holdings plc www.ekfdiagnostics.com
Christopher Mills, Non-executive Chairman Tel: +44 (0) 29 2071 0570
Julian Baines, CEO
Richard Evans, FD & COO
N+1 Singer Tel: 020 7496 3000
Aubrey Powell / George Tzimas / Tom
Salvesen
Walbrook PR Limited Tel: +44 (0) 20 7933 8780 or ekf@walbrookpr.com
Paul McManus / Lianne Cawthorne Mob: +44 (0) 7980 541 893 / +44 (0) 7584
391 303
About EKF Diagnostics Holdings plc ( www.ekfdiagnostics.com
)
EKF is a leading point-of-care diagnostics and central
laboratory assay manufacturer with an estimated 80,000 hemoglobin,
hematocrit, HbA1c, glucose and lactate analysers in regular use
across more than 100 countries. EKF specialises in developing tests
for use in anemia and diabetes diagnosis and management, as well as
providing a portfolio of reagents for use in clinical chemistry
analysers.
EKF specialises in the development, production and worldwide
distribution of point-of-care analyzers and clinical chemistry
reagents for use in hospital and research laboratories, doctor's
offices, blood banks and for in-field anaemia screening programmes.
EKF is also a bulk manufacturer of enzymes and has custom
manufacturing facilities in the USA for a variety of life science
products.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
MSCEAESSEFFFEFA
(END) Dow Jones Newswires
May 05, 2021 06:14 ET (10:14 GMT)
Ekf Diagnostics (LSE:EKF)
Historical Stock Chart
From Mar 2024 to Apr 2024
Ekf Diagnostics (LSE:EKF)
Historical Stock Chart
From Apr 2023 to Apr 2024